Puma Biotechnology logo AXA purchased a new position in Puma Biotechnology Inc (NASDAQ:PBYI) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 10,647 shares of the biopharmaceutical company’s stock, valued at …
30
Mar
Leave a Reply
You must be logged in to post a comment.